Biogen Inc (NASDAQ:BIIB) Stocks Tumble Over Potentially Unfavorable Outcome In Patent Battle FDA Headlines
Feb 12, 2019 | Business. Biogen Inc (NASDAQ:BIIB) Stocks Tumble Over Potentially Unfavorable Outcome In Patent Battle. Biogen Inc (NASDAQ:BIIB) closed …